SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis
Article Details
Authors (26)
Ren Luo
Min Yu
Kai Kang
Yufeng Zhang
Shanghai Liu
Zhuoran Yao
Zichong Peng
Xuanwei Zhang
Shuangsi Liao
Zhou Su
Linglu Yi
Hui Wang
Wenhao Zhao
Department of Biochemistry, Virginia Polytechnic Institute and State University
Yue Zheng
State Key Laboratory of Marine Environmental Science, College of the Environment and Ecology, Xiamen University
Guo Lin
Ruizhan Tong
Feifei Na
Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University
Youling Gong
Meijuan Huang
Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu
Bingwen Zou
Long Bai
Renming Zhong
Di Yan
Gabriele Niedermann
Jianxin Xue
Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University
You Lu
STFC Scientific Computing, Daresbury Laboratory